The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Latest Share Chat

ADN.L Share Price (ADN)

ADN.L Information

There is currently no data for ADN

3 Year ADN.L Share Chart

Great for

Spread Betting and CFDs

Capital at risk.

Great for

0% commission

Other fees apply.
Capital at risk.

Great for

Larger Investment Pots

Capital at risk.

Great for

Low Fees

Capital at risk.

London South East Users info for ADN.L

Users who watch ADN also watch: Barclays, BP, Aviva, Lloyds, Tesco, Vodafone, HSBC Holdings, Glaxosmithkline, Legal & General, Centrica.

Users who hold ADN also hold: Lloyds, Barclays, Glaxosmithkline, Vodafone, HSBC Holdings, BP, Legal & General, Aviva, BT, National Grid.

Recent Share Trades for ADN.L (ADN)

Date	Time	Trade Prc	Volume	Buy/Sell	Bid	Ask	Value
No trades found.

View more ADN.L trades

Directors Deals for ADN.L (ADN)

Announced	Traded	Action	Notifier	Price	Currency	Amount	Holding
27-Sep-16	26-Sep-16	Buy	Julie Chakraverty held the position of Non-Executive Director at the time of this trade.Julie Chakraverty	326.00	GBX	3,042	0
15-Sep-16	15-Sep-16	Sell	Roderick MacLeod (Rod) MacRae held the position of Group Risk Director at the time of this trade.Roderick MacLeod (Rod) MacRae	325.00	GBX	116,666	0
15-Sep-16	15-Sep-16	Sell	Martin J Gilbert held the position of CEO at the time of this trade.Martin J Gilbert	325.00	GBX	1,631,343	0
18-Jan-16	15-Jan-16	Buy	Simon Troughton held the position of Senior Independent Director at the time of this trade.Simon Troughton	224.20	GBX	10,000	70,000
18-Jan-16	15-Jan-16	Buy	Richard Stephen Mully held the position of Non-Executive Director at the time of this trade.Richard Stephen Mully	223.90	GBX	10,000	70,000

View more ADN.L directors deals

View more ADN.L share chat